Last reviewed · How we verify
PPS vaccine
At a glance
| Generic name | PPS vaccine |
|---|---|
| Sponsor | Sanofi |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo (PHASE2)
- An Immunity Persistence Study of Live Attenuated Varicella Vaccine (PHASE4)
- Pneumococcal Conjugate Vaccine in Aging Renal Transplant (EARLY_PHASE1)
- "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency (PHASE2)
- Pneumococcal Vaccination of Fiji Infants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PPS vaccine CI brief — competitive landscape report
- PPS vaccine updates RSS · CI watch RSS
- Sanofi portfolio CI